In line with a recent study of tumor-infiltrating T cells (33), these results also suggest that inhibiting CD226 signaling by TIGIT might be one of the major mechanisms by which TIGIT imparts its immune regulation in self-reactive T cells. Here, CD226 is linked to neoplasm.